Ligne de temps

Zhi Li
Ingénieur(e) de Recherche
20 oct. 2023
publication

Tick-borne flavivirus NS5 antagonizes interferon signaling by inhibiting the catalytic activity of TYK2.

Lire plus
09 août 2023
publication

Dissecting human population variation in single-cell responses to SARS-CoV-2

Lire plus
22 juin 2023
project

COVID-19-popCell – Genetic and infectious factors underlying population variability in immune responses to SARS-CoV-2

Lire plus
01 janv. 2022
publication

IFN-I inducible miR-3614-5p targets ADAR1 isoforms and fine tunes innate immune activation.

Lire plus
01 janv. 2020
publication

Two common disease-associated TYK2 variants impact exon splicing and TYK2 dosage.

Lire plus
11 mars 2019
publication

USP18 and ISG15 coordinately impact on SKP2 and cell cycle progression

Lire plus
21 déc. 2018
publication

Tuberculosis and impaired IL-23-dependent IFN-γ immunity in humans homozygous for a common missense variant

Lire plus
06 févr. 2017
publication

STAT2 is an essential adaptor in USP18-mediated suppression of type I interferon signaling

Lire plus
20 juin 2016
publication

Human USP18 deficiency underlies type 1 interferonopathy leading to severe pseudo-TORCH syndrome

Lire plus
19 mai 2016
publication

ISG15 deficiency and increased viral resistance in humans but not mice

Lire plus
29 avr. 2016
publication

The cyclin D1 carboxyl regulatory domain controls the division and differentiation of hematopoietic cells

Lire plus
15 sept. 2015
project

TYK2 variants in cytokine signaling and autoimmune diseases

Lire plus
15 sept. 2015
project

Fine-tuning of IFN-I response by USP18

Lire plus
11 mai 2015
team

Génétique Évolutive Humaine

Lire plus